GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (NAS:DCTH) » Definitions » E10

DCTH (Delcath Systems) E10 : $-2,009,750.00 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Delcath Systems E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Delcath Systems's adjusted earnings per share data for the three months ended in Sep. 2024 was $0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2,009,750.00 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 12.40% per year. During the past 5 years, the average E10 Growth Rate was 83.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Delcath Systems was 93.10% per year. The lowest was 12.40% per year. And the median was 92.10% per year.

As of today (2024-12-11), Delcath Systems's current stock price is $11.66. Delcath Systems's E10 for the quarter that ended in Sep. 2024 was $-2,009,750.00. Delcath Systems's Shiller PE Ratio of today is .


Delcath Systems E10 Historical Data

The historical data trend for Delcath Systems's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems E10 Chart

Delcath Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,446,290,000.00 -3,216,790.00 -2,754,510.00 -2,443,580.00 -2,164,710.00

Delcath Systems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,252,520.00 -2,164,710.00 -2,128,130.00 -2,069,330.00 -2,009,750.00

Competitive Comparison of Delcath Systems's E10

For the Medical Devices subindustry, Delcath Systems's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delcath Systems's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Shiller PE Ratio falls into.



Delcath Systems E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Delcath Systems's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.06/133.0289*133.0289
=0.060

Current CPI (Sep. 2024) = 133.0289.

Delcath Systems Quarterly Data

per share eps CPI Adj_EPS
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 -11,332,000.000 102.862 -14,655,368.977
201706 -647,667.000 103.349 -833,664.043
201709 -6,389.080 104.136 -8,161.784
201712 -60,833.800 104.011 -77,805.672
201803 5,610.460 105.290 7,088.583
201806 -5,080.480 106.317 -6,356.951
201809 -174.948 106.507 -218.513
201812 -738.484 105.998 -926.808
201903 -75.110 107.251 -93.163
201906 -58.500 108.070 -72.011
201909 -73.820 108.329 -90.651
201912 186.195 108.420 228.457
202003 -108.070 108.902 -132.013
202006 -1.900 108.767 -2.324
202009 -1.160 109.815 -1.405
202012 -1.172 109.897 -1.419
202103 -1.040 111.754 -1.238
202106 -0.960 114.631 -1.114
202109 -0.940 115.734 -1.080
202112 -0.690 117.630 -0.780
202203 -1.100 121.301 -1.206
202206 -1.240 125.017 -1.319
202209 -0.960 125.227 -1.020
202212 -0.843 125.222 -0.896
202303 -0.770 127.348 -0.804
202306 -0.580 128.729 -0.599
202309 -1.140 129.860 -1.168
202312 -0.330 129.419 -0.339
202403 -0.450 131.776 -0.454
202406 -0.480 132.554 -0.482
202409 0.060 133.029 0.060

Add all the adjusted EPS together and divide 10 will get our e10.


Delcath Systems  (NAS:DCTH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Delcath Systems E10 Related Terms

Thank you for viewing the detailed overview of Delcath Systems's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Delcath Systems Business Description

Traded in Other Exchanges
Address
566 Queensbury Avenue, Queensbury, NY, USA, 12804
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Executives
Gil Aharon director 15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7
Salamon Steven A J director 25 ADMIRAL ROAD, TORONTO A6 M5R 2L4
Vojo Vukovic officer: See Remarks C/O SYNTA PHARMACEUTICALS CORP., 45 HARTWELL AVENUE, LEXINGTON MA 02421
Gerard J Michel director, officer: Chief Executive Officer 420 CHIPETA WAY, SALT LAKE CITY UT 84108
Sandra Pennell officer: See Remarks C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139
David L. Hoffman officer: See Remarks C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
John Purpura officer: EVP, Regulatory Affairs 600 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10020
John Richard Sylvester director C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Rosalind Advisors, Inc. director, other: See Remarks 15 WELLESLEY STREET WEST, SUITE 326, TORONTO A6 M4Y 0G7
Kevin Muir officer: See Remarks C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Anthony Dias officer: Vice President of Finance C/O SEACHANGE INTERNATIONAL, 50 NAGOG PARK, ACTON MA 01720
Johnny John officer: See Remarks C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Elizabeth Czerepak director 201 ROUTE 17 NORTH, RUTHERFORD NJ 07070
Christine Padula officer: See Remarks C/O DELCATH SYSTEMS, INC., 1633 BROADWAY, SUITE 22C, NEW YORK NY 10019
Simon Pedder director 1001 MAIN STREET, SUITE 600, BUFFALO NY 14203